2004, Volume 11, Issue 05, pages 333-412

Beta blockers are under-used in heart failure, despite their evident benefits. Here an educational and clinical support link between secondary and primary care was set...

In the second commentary on echocardiography in the community, general practitioner Ed Southall writes about the new British Society of Echocardiography accreditation process and his...

A consensus statement from representatives of the British Society of Echocardiography, the British Heart Failure Society, the Coronary Heart Disease Collaborative and the Primary Care...

Peripartum cardiomyopathy (PPCM) is characterised by the development of left ventricular (LV) dilatation and dysfunction during the last month of pregnancy, or the first five...

Hypertension is the most important modifiable risk factor for stroke. The risk of stroke increases directly in proportion to systolic and diastolic blood pressure, and...

There has been a long-standing interest in the relation between what we eat and cardiovascular risk. Over the years, attention has been given to calories,...

The prevalence of anaemia in heart failure (HF) is becoming better recognised, yet little is known about its natural history in a HF population. We examined...

Implementation of new evidence-based guidelines is one of the most daunting tasks facing healthcare professionals today, and in order to meet this challenge we need...

Although studies from two decades ago documented the association of low haemoglobin with chronic heart failure (CHF), the potential for an important pathophysiological link has...

The pharmacological treatment of patients with chronic heart failure has changed dramatically over the past 25 years. This change began with the demonstration of the...